Articles Tagged With:
-
Measles Breaks Case Record, Hits 22 States and Big Apple
A record resurgence of measles in 2019 includes two large, ongoing outbreaks in New York, where the Centers for Disease Control and Prevention is helping hospitals and outpatient clinics prevent transmission from incoming cases. -
Legal Requirements May Conflict With Clinicians’ Ethical Obligations
It is simply not possible for clinicians to do the right thing if ethical principles and legal requirements are in direct conflict, experts say. But it is important not to lose sight of what the right thing is.
-
Remote Ethics Consults Help With Growing Demand for Onsite Ethics
Despite inherent limitations when the ethicist’s input comes instead from a screen or phone, some hospitals are moving toward remote ethics consults. Lack of robust ethics expertise onsite and a surge in demand are contributing factors.
-
Researchers: Cancer Screening Recommendations May Depend on Time of Day
In a recently published study, investigators sought find a connection between the likelihood a physician recommends patients undergo cancer screening and the time of the appointment.
-
New Tool Helps With Study Recruitment
Department of Energy researchers developed a new tool to connect cancer patients with clinical trials. The tool uses a Netflix-style of analytics to recommend studies that would be a good fit for particular patients.
-
Next Challenge for IRBs: Nanomedicine Research Risks
IRB members soon will see — if they haven’t already — protocols involving medical therapies with materials that are so tiny that a human hair is 80,000 times their width.
-
Diverse Populations Joining NIH All of Us
Nearly a quarter of a million people have joined the National Institutes of Health’s ambitious All of Us precision medicine initiative — with a large response from racial and ethnic minorities who have been historically victimized or ignored by human research.
-
Infectious Disease Alert Updates
California Inmates With Cocci Lose Appeal; Tuberculosis Testing in Small Children
-
Omadacycline (Nuzyra)
Omadacycline was approved in 2018 by the U.S. Food and Drug Administration (FDA) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
-
Histoplasmosis — Expansion of Risk Areas and Need for More Standardized Practice
Histoplasmosis is increasingly seen beyond the previous risk areas of the Ohio and Mississippi River valleys. Diagnostic and treatment practices vary widely.